Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absence, accrual, advisor, aforementioned, aspect, attach, baby, Center, collateral, commingled, consignment, content, contractor, correctly, counsel, creation, dedicated, deliberating, delinquency, dissuade, divestiture, dividend, earliest, FDIC, forecasted, foregoing, free, geopolitical, irrevocable, Junior, lessor, Lighthouse, methodology, military, Morphimmune, nonexclusive, nontransferable, onward, opportunistic, opt, outlicense, outlook, percent, perpetual, pill, poison, predecessor, prejudiced, pursuit, redesign, regularly, rental, resale, resell, retirement, shareholder, shelf, shell, spite, stability, staffing, strain, strength, sublessee, sublicense, thereof, thereunder, thought, Treaty, unaware, unchallenged, uncollectible, undertaken, undervalued, unemployment, Unified, unstable, upcoming, upward, vintage, win
Removed:
abbreviated, AbbVie, account, ADL, advancing, afflicted, AG, age, aged, agent, Alector, amyloid, analogy, ANDA, anniversary, antibiotic, antiviral, arm, assay, bacterial, base, beta, bilirubin, binding, Biogen, biomarker, block, cancelation, cancellable, cancelled, cap, carcinoma, cardiovascular, Cassava, catastrophic, causation, cavity, ceased, cell, cellular, Central, certification, characterized, chemical, Christopher, chronic, clearance, clinically, close, CNS, cognitive, cohort, community, competence, compliant, concentrated, concomitant, contact, contracting, contraindication, convenient, covalent, curtail, curtailed, cysteine, degeneration, deliver, Denali, desire, Detke, diagnostic, directorship, disaster, discontinuation, discovered, disrupt, diversified, division, Dominy, dysfunctional, dysplasia, earthquake, economical, educating, Eisai, Eli, EMA, enroll, enzyme, Equivalence, essential, evolve, experiencing, explanation, exploratory, extinguished, feet, fewer, field, forefront, Genentech, geographically, geologic, globally, group, guide, gum, harmful, harming, head, hepatic, Holding, home, hospitalization, IAS, immune, impeded, infection, inflammation, ingredient, inhibition, innovator, inpatient, insignificant, intranasal, irreversible, IV, leased, length, lengthened, leukoplakia, library, Lilly, line, liver, Lowe, lung, lysine, MAA, MAD, malignant, mandated, medication, Merck, mg, mice, Michael, mild, moderate, modification, month, mouse, Mpro, neck, neurodegeneration, neurodegenerative, Neurology, neuroprotective, notice, observed, obsolete, OLE, OPMD, optimal, oral, orally, Orange, outpatient, outweigh, overhead, Paragraph, partnering, pathogen, pathology, payer, penetrant, periodontal, persistent, pharmacodynamic, pharmacological, Pharmacology, physiological, planning, plaque, posed, potency, potent, powering, preceded, preclude, predicted, prevention, proactive, progression, proliferative, pronouncement, purport, PVL, randomization, rapid, receipt, recession, reference, remote, replication, requested, resignation, resigned, resistance, restrictive, resume, returned, reveal, revealed, reviewing, Roche, role, root, SAD, safer, scalable, scaling, scheduled, screening, selected, selective, selectivity, sequester, showed, shown, specialty, spread, square, stating, statistical, statistically, stay, stayed, Stephen, stepped, sue, suit, surrender, surveillance, systemic, tartar, telemetry, temporarily, temporary, terminating, therapy, tissue, tolerability, tooth, top, toxicity, transit, transition, travel, treating, understand, unmet, upper, utilizing, validate, validated, validation, vendor, version, viral, vital, voluntarily, withdrawing, worsen
Filing tables
Filing exhibits
QNCX similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
In connection with the Quarterly Report of Quince Therapeutics, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 15, 2023 | By: | /s/ Brendan Hannah | |
Brendan Hannah | |||
Chief Business Officer | |||
|
|
| (Principal Financial Officer) |